The Efficacy and Safety of Ornithine Aspartic Acid Granules in NAFLD Against Silymarin Capsules

NCT05042245 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

237

Enrollment

OTHER

Sponsor class

Conditions

Non-alcoholic Fatty Liver Disease

Interventions

DRUG: Ornithine aspartate granule
DRUG: Silymarin capsule
DRUG: Silymarin capsule simulant
DRUG: Ornithine aspartate granule simulant

Sponsor

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]